Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

428 ARTÍCULOS , VIENDO DEL 166 AL 180

Using Rotenone to Model Parkinson's Disease in Mice: A Review of the Role of Pharmacokinetics

Innos J, Hickey MA.

Chem Res Toxicol. 2021 May 17;34(5):1223-1239. doi: 10.1021/acs.chemrestox.0c00522. Epub 2021 May 7.

Focused Ultrasound Thalamotomy for Tremor-dominant Parkinson's Disease: A Prospective 1-year Follow-up Study

Yamamoto K, Ito H, Fukutake S, Odo T, Kamei T, Yamaguchi T, Taira T.

Neurol Med Chir (Tokyo). 2021 Jul 15;61(7):414-421. doi: 10.2176/nmc.oa.2020-0370. Epub 2021 May 8.

The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene

Kobiec T, Otero-Losada M, Chevalier G, Udovin L, Bordet S, Menéndez-Maissonave C, Capani F, Pérez-Lloret S.

Front Synaptic Neurosci. 2021 Apr 22;13:638519. doi: 10.3389/fnsyn.2021.638519. eCollection 2021.

Effect of Exercise on Parkinson's Disease Tremor: A Meta-analysis Study

Farashi S, Kiani L, Bashirian S.

Tremor Other Hyperkinet Mov (N Y). 2021 Apr 27;11:15. doi: 10.5334/tohm.599.

Factors associated with COVID-19 in people with Parkinson's disease: a systematic review and meta-analysis

Chambergo-Michilot D, Barros-Sevillano S, Rivera-Torrejón O, De la Cruz-Ku GA, Custodio N.

Eur J Neurol. 2021 Oct;28(10):3467-3477. doi: 10.1111/ene.14912. Epub 2021 Jun 9.

MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review

Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL.

Front Neurosci. 2021 Apr 30;15:660379. doi: 10.3389/fnins.2021.660379. eCollection 2021.

Novel Pharmacotherapies in Parkinson's Disease

Tizabi Y, Getachew B, Aschner M.

Neurotox Res. 2021 Aug;39(4):1381-1390. doi: 10.1007/s12640-021-00375-5. Epub 2021 May 18.

Tremor without parkinsonism: A new phenotype of autosomal-dominant striatal degeneration

Sun YM, Li HQ, Zhang Y.

Parkinsonism Relat Disord. 2021 Jun;87:122-123. doi: 10.1016/j.parkreldis.2021.05.003. Epub 2021 May 13.

Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson's disease and progressive supranuclear palsy

Takahashi K, Iwaoka K, Takahashi K, Suzuki Y, Taguchi K, Yamahara K, Maeda T.

Neurosci Lett. 2021 Jul 13;757:135975. doi: 10.1016/j.neulet.2021.135975. Epub 2021 May 21.

Dynamic Tremor in a Patient With Parkinson Disease

França C, Duarte KP, Cury RG.

JAMA Neurol. 2021 Aug 1;78(8):1015. doi: 10.1001/jamaneurol.2021.1431.

Immunotherapies for Parkinson's Disease: Progression of Clinical Development

Teng JS, Ooi YY, Chye SM, Ling APK, Koh RY.

CNS Neurol Disord Drug Targets. 2021;20(9):802-813. doi: 10.2174/1871527320666210526160926.

Tremor and Parkinsonism in Chromosomopathies - A Systematic Review

Carvalho V, Ferreira JJ, Correia Guedes L.

Mov Disord. 2021 Sep;36(9):2017-2025. doi: 10.1002/mds.28663. Epub 2021 May 31.

Golf as a Physical Activity to Potentially Reduce the Risk of Falls in Older Adults with Parkinson's Disease

Bliss RR, Church FC.

Sports (Basel). 2021 May 23;9(6):72. doi: 10.3390/sports9060072.

Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study

D'Alessandro R, Zenesini C, Baldin E, Bonavina G, Calandra-Buonaura G, Cortelli P, Fabbri G, Guarino M, Nassetti SA, Pantieri R, Samoggia G, Nonino F, Vignatelli L; ParkLink Bologna group.

Parkinsonism Relat Disord. 2021 Jun;87:137-141. doi: 10.1016/j.parkreldis.2021.04.023. Epub 2021 May 6.

An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with α-synucleinopathy

Sakuwa M, Adachi T, Yoshida K, Adachi Y, Nakano T, Hanajima R.

Neuropathology. 2021 Aug;41(4):293-300. doi: 10.1111/neup.12735. Epub 2021 Jun 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias